Boundless Bio

Boundless Bio

    Company info:

  • 51-100
  • 2018
  • La Jolla, CA
  • 100-500M


Claim company profile

About company:

Boundless Bio is developing therapeutics directed against extrachromosomal DNA (eDNA) to treat the most intractable cancers. ecDNAs are large units of circular DNA that reside within the cell nucleus yet are distinct from the chromosomal DNA. As ecDNAs can encode genes, they provide a mechanism for higher copy numbers of oncogenes, genes that are known to drive aggressive tumor growth and resistance to cancer treatments. Boundless has identified ecDNA as a differentiating feature of cancer cells that does not exist in normal cells. By further characterizing the biology of ecDNAs using their Spyglass platform, Boundless is generating a broad pipeline of ecDNA-directed therapies (ecDTx) to target gene amplified cancers.


Boundless Bio
Associate Director/Director, Drug Substance Develo...
San Diego, CA|38 days ago
Boundless Bio
Director/Senior Director, Drug Discovery Biology
San Diego, CA|43 days ago
Boundless Bio
Associate Director/Director, Chemistry
San Diego, CA|71 days ago

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy